Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial

Nature medicine · 2026 Nov 8 · Borlaug BA, Jensen MD, Packer M et

By Maren Holt · Senior Reporter, GLP-1

From the source

Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial
Nature medicine · 2026 Nov 8 · Borlaug BA, Jensen MD, Packer M et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/43000472/